References
- Richardson CT. Gastric ulcer. In: Sleisenger MH, Fordtran JS, eds. Gastrointestinal disease: pathophysiology, diagnosis, management. 4th ed. Philadelphia: Saunders, 1989: 879–909
- Soll AH. Duodenal ulcer and drug therapy. In: Sleisenger, Fordtran, eds,1 pp 814–79
- Emas S. Medical principles for treatment of peptic ulcer. Scand J Gastroenterol Suppl 1987: 137: 28–32
- Forssell H. Gastric mucosal defense mechanisms: a brief review. Scand J Gastroenterol Suppl 1988: 155: 23–8
- Soll AH, Kurata J, McGuigan JE. Ulcers, nonsteroidal antiinflammatory drugs, and related matters. Gastroenterology 1989: 96 (2 Pt 2 Suppl): 561–8
- Eastwood GL. Epithelial renewal in protection and repair of gastroduodenal mucosa. J Clin Gastroenterol 1991: 13(Suppl 1): S48–53
- Wilson DE. Role of prostaglandins in gastroduodenal mucosal protection. J Clin Gastroenterol 1991: 13(Suppl 1): S65–71
- Takeuchi T, Shiratori K, Watanabe S, et al. Secretin as a potential mediator of antiulcer actions of mucosal protective agents. J Clin Gastroenterol 1991: 13(Suppl 1): S83–7
- Tarnawski A, Stachura J, Krause WJ, et al. Quality of gastric ulcer healing: a new, emerging concept. J Clin Gastroenterol 1991: 13(Suppl 1): S42–7
- Feldman M. Gastric secretion in health and disease. In: Sleisenger, Fordtran, eds,1 pp 713–34
- Chiverton SG, Hunt RH. Relationship between inhibition of acid secretion and healing of peptic ulcers. Scand J Gastroenterol Suppl 1989: 166: 43–7
- Piper JM, Ray WA, Daugherty JR, et al. Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs. Ann Intern Med 1991: 114(9): 735–40
- Graham DY. Campylobacter pylori and peptic ulcer disease. Gastroenterology 1989: 96(2 Pt 2 Suppl): 615–25
- Wyle FA. Helicobacter pylori: current perspectives. J Clin Gastroenterol 1991: 13 (Suppl 1): S114–24
- Cover TL, Blaser MJ. Helicobacter pylori and gastroduodenal disease. Annu Rev Med 1992: 43: 135–45
- Graham DY, Lew GM, Klein PD, et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer: a randomized, controlled study. Ann Intern Med 1992: 116(9): 705–8
- Glupczynski Y, Burette A. Drug therapy for Helicobacter pylori infection: problems and pitfalls. Am J Gastroenterol 1990: 85(12): 1545–51
- Alam K, Schubert TT, Bologna SD, et al. Increased density of Helicobacter pylori on antral biopsy is associated with severity of acute and chronic inflammation and likelihood of duodenal ulceration. Am J Gastroenterol 1992: 87(4): 424–8
- Graham DY, Lew GM, Evans DG, et al. Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing: a randomized controlled trial. Ann Intern Med 1991: 115(4): 266–9
- Sewing KF. Efficacy of low-dose antacids in the treatment of peptic ulcers: pharmacological explanation? J Clin Gastroenterol 1991: 13(Suppl l): S134–8
- Nauert C, Caspary WF. Duodenal ulcer therapy with low-dose antacids: a multicenter trial. J Clin Gastroenterol 1991: 13(Suppl 1): S149–54
- Tarnawski A, Konturek JT, Wilson S, et al. Mechanisms of mucosal protective and healing action of antacids and other topically active agents: facts, hypotheses, and speculations. J Clin Gastroenterol 1991: 13(Suppl 1): S155–60
- McCarthy DM. Sucralfate. N Engl J Med 1991: 325(14): 1017–25
- Walt RP. Misoprostol for the treatment of peptic ulcer and antiinflammatory-drug—induced gastroduodenal ulceration. N Engl J Med 1992: 327(22): 1575–80
- Cantu TG, Korek JS. Central nervous system reactions to histamine-2 receptor blockers. Ann Intern Med 1991: 114(12): 1027–34